Rocket Pharmaceuticals (RCKT) News Today $16.63 -0.62 (-3.59%) (As of 10/9/2024 ET) Add Compare Share Share Headlines Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestSustainabilityTrends All Sources Trusted Sources MarketBeat.com Benzinga Bloomberg MarketWatch Motley Fool NASDAQ PR Newswire Reuters Seeking Alpha The Street The Wall Street Journal Yahoo Finance Source Sentiment refers to the positivity or negativity of each headline according to our language processing algorithm. Sentiment All Sentiments Very Positive Positive Neutral Negative Very Negative Most Recent October 2024 September 2024 August 2024 July 2024 June 2024 May 2024 April 2024 March 2024 February 2024 January 2024 December 2023 November 2023 October 2023 September 2023 August 2023 July 2023 June 2023 May 2023 April 2023 March 2023 February 2023 January 2023 December 2022 November 2022 October 2022 September 2022 August 2022 July 2022 June 2022 May 2022 April 2022 March 2022 February 2022 January 2022 December 2021 November 2021 Time Period Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 3.8% - Here's What HappenedRocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 3.8% - What's Next?October 9 at 3:21 PM | marketbeat.comDimensional Fund Advisors LP Reduces Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Dimensional Fund Advisors LP lessened its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 8.1% during the 2nd quarter, according to the company in its most recent 13F filing with the SEC. The firm owned 946,175 shares of the biotechnology company's stock after sellOctober 4, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Reaches New 52-Week Low at $16.03October 3, 2024 | americanbankingnews.comNHL 2024-25 awards predictions: Picks for Calder, Rocket Richard, Hart and moreOctober 3, 2024 | nytimes.comRocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 7.4%October 3, 2024 | americanbankingnews.comRenaissance Technologies LLC Acquires New Shares in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Renaissance Technologies LLC purchased a new position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) during the second quarter, according to its most recent 13F filing with the Securities and Exchange Commission (SEC). The institutional investor purchased 99,574 shares of thOctober 3, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 7.4%Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 7.4%October 1, 2024 | marketbeat.comUS FAA Grounds SpaceX's Falcon 9 Rocket After Second-Stage MalfunctionSeptember 30, 2024 | usnews.comRocket Attack Targets Military Base Hosting US Forces in Baghdad, Military Sources SaySeptember 30, 2024 | usnews.comRocket Pharmaceuticals (NASDAQ:RCKT) Stock Rating Reaffirmed by Canaccord Genuity GroupSeptember 30, 2024 | americanbankingnews.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Shares Bought by Novo Holdings A SNovo Holdings A S grew its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 4.8% in the 2nd quarter, according to the company in its most recent filing with the Securities and Exchange Commission. The institutional investor owned 1,100,000 shares of the biotechnoloSeptember 30, 2024 | marketbeat.comRocket Lab soars to new 52-week high on signs that revenue growth can take offSeptember 27, 2024 | msn.comMaverick Capital Ltd. Acquires 40,000 Shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Maverick Capital Ltd. grew its holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 1.0% in the second quarter, according to the company in its most recent Form 13F filing with the SEC. The institutional investor owned 3,928,312 shares of the biotechnology company's stock afterSeptember 27, 2024 | marketbeat.comProfund Advisors LLC Decreases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Profund Advisors LLC cut its holdings in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 56.6% during the 2nd quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The fund owned 22,201 shares of the biotechnology company's stSeptember 26, 2024 | marketbeat.comRocket Lab USA's Options: A Look at What the Big Money is ThinkingSeptember 25, 2024 | benzinga.comChina Says It Launched a Rocket With a Dummy Warhead Into the PacificSeptember 25, 2024 | nytimes.comLogos Global Management LP Has $7.54 Million Stock Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Logos Global Management LP cut its position in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 73.1% during the 2nd quarter, according to the company in its most recent Form 13F filing with the SEC. The fund owned 350,000 shares of the biotechnology company's stock after selliSeptember 24, 2024 | marketbeat.comRocket Lab Launches 53rd Electron Mission, Deploying Five Satellites For KinéisSeptember 23, 2024 | benzinga.comHezbollah Retaliates Against Israel With Rocket BarrageSeptember 22, 2024 | nytimes.comDan Gilbert wants to make more Rocket shares available. How that could affect the companySeptember 21, 2024 | detroitnews.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Given Consensus Recommendation of "Moderate Buy" by AnalystsRocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) has received a consensus rating of "Moderate Buy" from the nine brokerages that are covering the stock, MarketBeat.com reports. One analyst has rated the stock with a hold recommendation and eight have assigned a buy recommendation toSeptember 20, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 3.5% Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 3.5%September 18, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Trading 6.4% Higher Rocket Pharmaceuticals (NASDAQ:RCKT) Trading 6.4% HigherSeptember 17, 2024 | marketbeat.comRocket Pharmaceuticals (NASDAQ:RCKT) Earns "Buy" Rating from Needham & Company LLCNeedham & Company LLC reissued a "buy" rating and set a $52.00 price objective on shares of Rocket Pharmaceuticals in a research note on Tuesday.September 17, 2024 | marketbeat.comPentagon Awards Rocket Motor Maker Ursa Major $12.5 MillionSeptember 17, 2024 | usnews.comRocket Pharmaceuticals: 2 Gene Therapy Candidates Anticipating Near-Term ReviewSeptember 15, 2024 | seekingalpha.comNicki Minaj and colorful Barbz turn Rocket Mortgage FieldHouse into ‘Gag City’ on Pink Friday the 13thSeptember 15, 2024 | msn.comFirst Turn Management LLC Has $12.08 Million Position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)First Turn Management LLC boosted its position in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 123.6% during the second quarter, according to the company in its most recent 13F filing with the SEC. The fund owned 560,989 shares of the biotechnology company's stock after buying an addSeptember 13, 2024 | marketbeat.comRocket Pharmaceuticals Announces Appointment of Mikael Dolsten, M.D., Ph.D., to Board of DirectorsSeptember 10, 2024 | finance.yahoo.com'Pathfinder' hoisted back into place at U.S. Space & Rocket CenterAugust 31, 2024 | msn.comPathfinder shuttle to return to U.S. Space & Rocket Center after restorationAugust 28, 2024 | yahoo.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up to $18.59Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Gap Up to $18.59August 26, 2024 | marketbeat.comRocket Pharmaceuticals, Inc. (NASDAQ:RCKT) Receives Average Rating of "Moderate Buy" from AnalystsShares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Get Free Report) have earned an average rating of "Moderate Buy" from the ten research firms that are currently covering the firm, MarketBeat.com reports. One research analyst has rated the stock with a hold recommendation and nine have assigneAugust 26, 2024 | marketbeat.comRocket Lab: Way More Upside Than Previously ThoughtAugust 24, 2024 | seekingalpha.comRocket Lab Owns 2/3 of the U.S. Launch Market -- That Isn't SpaceXAugust 24, 2024 | fool.comAssenagon Asset Management S.A. Has $646,000 Stock Holdings in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Assenagon Asset Management S.A. trimmed its stake in shares of Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 62.9% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 29,986 shares of theAugust 24, 2024 | marketbeat.comRocket Mortgage Canada Review 2024August 23, 2024 | forbes.comRocket Pharmaceuticals (NASDAQ:RCKT) Trading Down 5.8%Rocket Pharmaceuticals (NASDAQ:RCKT) Stock Price Down 5.8%August 22, 2024 | marketbeat.comRocket Engine Explodes During Test in ScotlandAugust 21, 2024 | nytimes.comHennion & Walsh Asset Management Inc. Decreases Stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT)Hennion & Walsh Asset Management Inc. lowered its stake in Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) by 11.8% in the second quarter, according to the company in its most recent Form 13F filing with the Securities and Exchange Commission. The fund owned 204,110 shares of the biotechnoAugust 19, 2024 | marketbeat.comRocket League Sideswipe Codes (August 2024)August 15, 2024 | msn.comRocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 4.9% Rocket Pharmaceuticals (NASDAQ:RCKT) Shares Down 4.9%August 14, 2024 | marketbeat.comCharles R. Cross, Music Journalist Who Wrote Heralded Kurt Cobain Biography and Edited Seattle's Alt-Weekly the Rocket, Dies at 67August 12, 2024 | msn.comFY2024 Earnings Forecast for Rocket Pharmaceuticals, Inc. Issued By Chardan Capital (NASDAQ:RCKT)Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Investment analysts at Chardan Capital lowered their FY2024 earnings estimates for shares of Rocket Pharmaceuticals in a research note issued on Tuesday, August 6th. Chardan Capital analyst Y. Livshits now forecasts that the biotechnologyAugust 9, 2024 | marketbeat.comCantor Fitzgerald Weighs in on Rocket Pharmaceuticals, Inc.'s FY2024 Earnings (NASDAQ:RCKT)Rocket Pharmaceuticals, Inc. (NASDAQ:RCKT - Free Report) - Research analysts at Cantor Fitzgerald raised their FY2024 earnings per share estimates for Rocket Pharmaceuticals in a note issued to investors on Tuesday, August 6th. Cantor Fitzgerald analyst J. Schimmer now expects that the biotechnolAugust 8, 2024 | marketbeat.comTickets for 2024 Rock Hall induction ceremony at Rocket Mortgage Fieldhouse go on sale this weekAugust 7, 2024 | msn.comSolid Clinical Progress and Strong Financial Position Reinforce Buy Rating for Rocket PharmaceuticalsAugust 7, 2024 | markets.businessinsider.comBuy Rating Affirmed on Rocket Pharmaceuticals Amid Promising Gene Therapy Advances and Solid FinancialsAugust 6, 2024 | markets.businessinsider.comPat Ammons speaks on the return of the spaceline and Rocket RowAugust 6, 2024 | msn.com5 US Troops, 2 Contractors Hurt in Rocket Attack as Details Emerge About Strike at Iraq BaseAugust 6, 2024 | usnews.com Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address These 5 stocks could soar after November 4th (Ad)Earnings Season: Your FREE Ticket to Trading Success Don't just survive earnings season - learn how to potentially thrive. Discover how to time your trades for maximum potential profit. Bonus: Daily earnings updates delivered straight to your inbox. Click here now to claim your free guide before this offer expires! RCKT Media Mentions By Week RCKT Media Sentiment Learn about the media sentiment score. Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press. RCKT News Sentiment▼0.320.68▲Average Medical News Sentiment RCKT News Coverage Learn about the media coverage comparison. We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week. RCKT Articles This Week▼76▲RCKT Articles Average Week Get Rocket Pharmaceuticals News Delivered to You Automatically Sign up to receive the latest news and ratings for RCKT and its competitors with MarketBeat's FREE daily newsletter. Email Address Related Companies and Tools Related Companies: RCUS News Today AUPH News Today YMAB News Today HRTX News Today MRSN News Today AMRN News Today GBIO News Today MDGL News Today CYTK News Today BPMC News Today Headlines Tools: Trending Media MentionsHigh Media Sentiment StocksLive News FeedMarketBeat OriginalsStock Ideas This page (NASDAQ:RCKT) was last updated on 10/10/2024 by MarketBeat.com Staff From Our PartnersBigger Than Nvidia?Bigger Than Nvidia? Wall Street legend has just uncovered one tiny Maryland company that could become the n...InvestorPlace | SponsoredWar on Elon Escalates… A radical, potentially game-changing technology that threatens to destroy the trillion-dollar, “green energy” ...Porter & Company | Sponsored24/7 Automated Profits in CryptoWhat if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...Crypto Swap Profits | SponsoredWhat Is the $7,882 Stimulus Payment 2024?Biden’s government just announced a new government "stimulus program"... And it could hand you a payment fo...Angel Publishing | Sponsored320 hedge funds just sold this stock320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are alr...Chaikin Analytics | SponsoredAI Expert Reveals New PickWhy You Shouldn't Pour All Your Money Into Nvidia Jeff Brown, who predicted Nvidia's rise, warns against pu...Brownstone Research | SponsoredClaim Your FREE "AI Income Playbook" Now!Income expert Marc Lichtenfeld has a special gift reserved just for you... It's his brand-new "AI Income Pl...The Oxford Club | SponsoredThis unknown company solves the biggest issue with AINvidia is the 800-lb gorilla in AI chips. But… it has a big problem. That's where one tiny company comes in...Manward Press | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Rocket Pharmaceuticals, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Rocket Pharmaceuticals With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Your Password: Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Choose a Password: Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
